|
Micafungin as anti-fungal prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients |
20-Oct |
|
|
|
Significant Drug Interaction between Voriconazole and Ciclosporin in Paediatric Allogeneic Haematopoietic Stem Cell Transplant Recipients |
20-Oct |
|
|
|
Infectious complications and long-term outcome of HIV-1 patients after autologous peripheral blood stem cell transplant: review of a 15-year single institution experience |
20-Oct |
|
|
|
Hematopoietic Cell Transplantation Comorbidity Index as prognostic variable in patients with Invasive Fungal Disease (IFD) |
20-Oct |
|
|
|
Comparative results between micafungin and intravenous itraconazole as primary anti-fungal prophylaxis in allogeneic stem cell transplantation. Retrospective study in a single centre |
20-Oct |
|
|
|
The role of galactomannan test in bronchoalveolar lavage in the diagnosis of invasive aspergillosis in children after hematopoietic stem cells transplantation |
20-Oct |
|
|
|
Infections in the first year after Haploidentical Stem Cell Transplantation with post-transplant Cyclophosphamide |
20-Oct |
|
|
|
Optimization and scale up production of aspergillus- and multipathogen-specific T cells for adoptive immunotherapy |
20-Oct |
|
|
|
Validation of a risk score for post-engraftment invasive fungal disease in 414 adult allogeneic hematopoietic stem cell transplant recipients |
20-Oct |
|
|
|
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic cell transplantation |
20-Oct |
|
|
